Pulse Biosciences Inc. (PLSE) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pulse Biosciences Inc. (PLSE:NASDAQ), powered by AI.

Current Price
$25.11
Sector
Healthcare
What is the Pulse Biosciences Inc. stock price forecast?

Pulse Biosciences Inc. is currently trading at $25.11. View real-time AI analysis on Alpha Lenz.

What is Pulse Biosciences Inc. insider trading activity?

View the latest insider trading data for Pulse Biosciences Inc. on Alpha Lenz.

What is Pulse Biosciences Inc.'s P/E ratio?

View Pulse Biosciences Inc.'s valuation metrics on Alpha Lenz.

Pulse Biosciences Inc.

NASDAQ · PLSE
$25.11-0.82(-3.14%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Pulse Biosciences Inc.'s future dividend policy...
Alpha Chat Insight

Pulse Biosciences Inc.'s ROE is -74.4%. Explore profitability and growth together.

Ask for details

Company Overview

Pulse Biosciences Inc. is a bioelectric medicine company that leverages its novel Nano-Pulse Stimulation technology to treat a variety of medical conditions. This technology employs precise pulses of electrical energy to stimulate cells, primarily aimed at dermatology and oncology applications. Pulse Biosciences Inc. focuses on developing innovative solutions that provide significant clinical benefits, offering non-thermal and non-invasive treatment options. The company's groundbreaking approach has the potential to transform treatment paradigms across multiple sectors, including aesthetics, oncology, and dermatologic disorders. By providing solutions that are less invasive and potentially more effective than traditional methods, Pulse Biosciences plays a critical role in advancing the medical technology landscape. The company's contributions are increasingly significant in the context of personalized medicine and targeted treatment strategies, showcasing the expanding capabilities of bioelectric medical treatments in modern healthcare.

CEOMr. Paul Arthur LaViolette
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees75

Company Statistics

FY 2025

Profile

N/AMarket Cap
$350.00KRevenue
0.00Shares Out
75Employees

Margins

-54.00%Gross
-21676.57%EBITDA
-21982.57%Operating
-20794.57%Pre-Tax
-20794.57%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-20.63%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-64.12%ROA
-74.45%ROE
-67.79%ROIC

Financial Health

$80.73MCash & Cash Equivalents
$-66.85MNet Debt
17.21%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Pulse Biosciences Inc. (ticker: PLSE) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 75 employees.

The current price is $25.11 with a P/E ratio of -x and P/B of -x.

ROE is -74.45% and operating margin is -21982.57%. Annual revenue is $350,000.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Pulse Biosciences Inc. (PLSE) Stock Forecast 2026 $25.11 — Price, Financials & Analyst Targets | Alpha Lenz